Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.

Mechanism of Action of Paracetamol

Graham, Garry G., Scott, Kieran F. · 2005 · American Journal of Therapeutics

Abstract

Paracetamol (acetaminophen) is generally considered to be a weak inhibitor of the synthesis of prostaglandins (PGs). However, the in vivo effects of paracetamol are similar to those of the selective cyclooxygenase-2 (COX-2) inhibitors. Paracetamol also decreases PG concentrations in vivo, but, unlike the selective COX-2 inhibitors, paracetamol does not suppress the inflammation of rheumatoid arthritis. It does, however, decrease swelling after oral surgery in humans and suppresses inflammation in rats and mice. Paracetamol is a weak inhibitor of PG synthesis of COX-1 and COX-2 in broken cell systems, but, by contrast, therapeutic concentrations of paracetamol inhibit PG synthesis in intact cells in vitro when the levels of the substrate arachidonic acid are low (less than about 5 mumol/L). When the levels of arachidonic acid are low, PGs are synthesized largely by COX-2 in cells that contain both COX-1 and COX-2. Thus, the apparent selectivity of paracetamol may be due to inhibition of COX-2-dependent pathways that are proceeding at low rates. This hypothesis is consistent with the similar pharmacological effects of paracetamol and the selective COX-2 inhibitors. COX-3, a splice variant of COX-1, has been suggested to be the site of action of paracetamol, but genomic and kinetic analysis indicates that this selective interaction is unlikely to be clinically relevant. There is considerable evidence that the analgesic effect of paracetamol is central and is due to activation of descending serotonergic pathways, but its primary site of action may still be inhibition of PG synthesis. The action of paracetamol at a molecular level is unclear but could be related to the production of reactive metabolites by the peroxidase function of COX-2, which could deplete glutathione, a cofactor of enzymes such as PGE synthase.

Overview

Integrity signals

Registry

Crossref · 10.1097/00045391-200501000-00008

Cites

74 of 74 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 74 references

Research works printed but not linked: 5

  1. Wong, 1983, J Pharmacol Exp Ther, 226, 625
  2. Swierkosz, 2002, Med Sci Monit, 8, BR496
  3. Thompson, 1989, Mol Pharmacol, 36, 809
  4. Pelissier, 1996, J Pharmacol Exp Ther, 278, 8
  5. Riendeau, 1997, Can J Physiol Pharmacol, 75, 1088, 10.1139/y97-130 · doi:10.1139/y97-130 · Paper page

Cited by

See all 648

Metadata

Authors
Graham, G. G., & Scott, K. F.
Affiliations
  • UNSW Sydney (AU)
  • St Vincent's Hospital Sydney (AU)
Corresponding author
Graham, Garry G.
Venue
American Journal of Therapeutics
Published
2005-01
Volume
12
Issue
1
Pages
46-55
ISSN
1075-2765 (ISSN-L)
OpenAlex
W1981760474
Cited by
648
References
74
Citations by year
2026: 26 · 2025: 34 · 2024: 21 · 2023: 44 · 2022: 22 · 2021: 42 · 2020: 34 · 2019: 38 · 2018: 26 · 2017: 32 · 2016: 26 · 2015: 34 · 2014: 35 · 2013: 33 · 2012: 35
FWCI
2.68
Type
journal article
Language
en
Open access
closed
Locations
  • American Journal of Therapeutics (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • GlaxoSmithKline
  • National Health and Medical Research Council
  • National Medical Research Council
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
  • Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
Keywords
paracetamol, mechanism of action, prostaglandin synthesis, cyclooxygenase-2, cyclooxygenase-1, COX-3, arachidonic acid, COX-2 inhibitors, analgesia, descending serotonergic pathways, glutathione depletion, inflammation, rheumatoid arthritis
MeSH terms
Acetaminophen, Animals, Humans, Pain, Prostaglandins, Cyclooxygenase Inhibitors, Analgesics, Non-Narcotic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Mechanism of Action of Paracetamol. https://app.cochat.ai/papers/10.1097/00045391-200501000-00008
The paper
Graham, G. G., & Scott, K. F. (2005). Mechanism of Action of Paracetamol. American Journal of Therapeutics. https://doi.org/10.1097/00045391-200501000-00008

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.